Jeffrey V. Poulton
2021
Compensation breakdown
| Non-Equity Incentive Plan | $330,630 |
|---|---|
| Option Awards | $1,884,125 |
| Salary | $569,200 |
| Other | $14,220 |
| Total | $2,798,175 |
Poulton received $1.9M in option awards, accounting for 67% of the total pay in 2021.
Poulton also received $330.6K in non-equity incentive plan, $569.2K in salary and $14.2K in other compensation.
Rankings
In 2021, Jeffrey V. Poulton's compensation ranked 4,701st out of 12,415 executives tracked by ExecPay. In other words, Poulton earned more than 62.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,701 out of 12,415 | 62nd |
Division Manufacturing | 1,953 out of 5,505 | 65th |
Major group Chemicals And Allied Products | 817 out of 2,375 | 66th |
Industry group Drugs | 730 out of 2,096 | 65th |
Industry Pharmaceutical Preparations | 521 out of 1,546 | 66th |
Pay ratio
| Jeffrey V. Poulton's Pay | $2,798,175 |
|---|---|
| Median Employee's Pay | $231,163 |
| Pay Ratio | 12to 1 |
In 2021, the annual total compensation of Jeffrey V. Poulton was $2,798,175.
The annual total compensation of the median employee at Alnylam Pharmaceuticals was $231,163.
The ratio of Jeffrey V. Poulton's pay to the pay of median employee was therefore 12 to one.
Poulton's colleagues
We found four more compensation records of executives who worked with Jeffrey V. Poulton at Alnylam Pharmaceuticals in 2021.
2021
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2021
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2021
Tolga Tanguler
Alnylam Pharmaceuticals
Executive Vice President, Chief Commercial Officer
2021
Akshay Vaishnaw
Alnylam Pharmaceuticals